Browse > Article
http://dx.doi.org/10.14476/jomp.2022.47.4.174

Management of Chronic Pain in Temporomandibular Disorders  

Kyung-Hee Kim (Department of Oral Medicine, Pusan Paik Hospital, Inje University)
Hye-Min Ju (Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry)
Sung-Hee Jeong (Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry)
Yong-Woo Ahn (Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry)
Hye-Mi Jeon (Dental Clinic Center, Pusan National University Hospital, Busan, Korea)
Soo-Min Ok (Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry)
Publication Information
Journal of Oral Medicine and Pain / v.47, no.4, 2022 , pp. 174-182 More about this Journal
Abstract
In chronic temporomandibular disorders (TMDs), constituent tissues such as muscles are sensitive to pain and psychological stress, which negatively affect the quality of life. In addition, since chronic TMDs is often accompanied by diseases such as psychological disorders and other chronic pain disorders, the diagnosis of those diseases and patient referrals are mandatory. The management of chronic pain in TMDs requires a multidisciplinary and holistic approach. Pharmacological therapy using cyclobenzaprine, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, progressive relaxation, and psychological approaches using cognitive behavioral therapy such as shifting negative thoughts about pain are all valid treatment options.
Keywords
Chronic pain; Pharmacological therapy; Temporomandibular joint disorders;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, Ambrosano GM, de Barbosa JR. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio 2003;21:221-225.    DOI
2 McQuay HJ, Carroll D, Glynn CJ. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 1993;48:281-285.    DOI
3 McQuay HJ, Moore RA. Antidepressants and chronic pain. BMJ 1997;314:763-764.    DOI
4 Briley M. Clinical experience with dual action antidepressants in different chronic pain syndromes. Hum Psychopharmacol 2004;19 Suppl 1:S21-S25.    DOI
5 Hersh EV, Balasubramaniam R, Pinto A. Pharmacologic management of temporomandibular disorders. Oral Maxillofac Surg Clin North Am 2008;20:197-210, vi.    DOI
6 Wang GYF, Shi XQ, Wu W, Gueorguieva M, Yang M, Zhang J. Sustained and repeated mouth opening leads to development of painful temporomandibular disorders involving macrophage/microglia activation in mice. Pain 2018;159:1277-1288.    DOI
7 Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain 1997;11:139-146. 
8 Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandib Disord 1991;5:179-186. 
9 DeNucci DJ, Sobiski C, Dionne RA. Triazolam improves sleep but fails to alter pain in TMD patients. J Orofac Pain 1998;12:116-123. 
10 Swift JQ, Roszkowski MT. The use of opioid drugs in management of chronic orofacial pain. J Oral Maxillofac Surg 1998;56:1081-1085.    DOI
11 Simons DG, Travell JG, Simons LS, Cummings BD. Myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore: Williams & Wilkins; 1999. pp. 94-173. 
12 Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician 2002;65:653-660. 
13 Gardea MA, Gatchel RJ, Mishra KD. Long-term efficacy of biobehavioral treatment of temporomandibular disorders. J Behav Med 2001;24:341-359.    DOI
14 Mishra KD, Gatchel RJ, Gardea MA. The relative efficacy of three cognitive-behavioral treatment approaches to temporomandibular disorders. J Behav Med 2000;23:293-309.    DOI
15 Noma N, Watanabe Y, Shimada A, et al. Effects of cognitive behavioral therapy on orofacial pain conditions. J Oral Sci 2020;63:4-7.    DOI
16 de Barros Pascoal AL, de Freitas RFCP, da Silva LFG, Oliveira AGRC, Dos Santos Calderon P. Effectiveness of counseling on chronic pain management in patients with temporomandibular disorders. J Oral Facial Pain Headache 2020;34:77-82.    DOI
17 Kerns RD, Rosenberg R. Predicting responses to self-management treatments for chronic pain: application of the pain stages of change model. Pain 2000;84:49-55.    DOI
18 Oral A, Ilieva EM, Kucukdeveci AA, et al. Generalised and regional soft tissue pain syndromes. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee. Eur J Phys Rehabil Med 2013;49:535-549. 
19 Carlson CR, Bertrand PM, Ehrlich AD, Maxwell AW, Burton RG. Physical self-regulation training for the management of temporomandibular disorders. J Orofac Pain 2001;15:47-55. 
20 Wright EF, Domenech MA, Fischer JR Jr. Usefulness of posture training for patients with temporomandibular disorders. J Am Dent Assoc 2000;131:202-210.    DOI
21 Feine JS, Lund JP. An assessment of the efficacy of physical therapy and physical modalities for the control of chronic musculoskeletal pain. Pain 1997;71:5-23.    DOI
22 Martin-Pintado Zugasti A, Rodriguez-Fernandez AL, Garcia-Muro F, et al. Effects of spray and stretch on postneedling soreness and sensitivity after dry needling of a latent myofascial trigger point. Arch Phys Med Rehabil 2014;95:1925-1932.e1.    DOI
23 Cho SH, Whang WW. Acupuncture for temporomandibular disorders: a systematic review. J Orofac Pain 2010;24:152-162. 
24 Jung A, Shin BC, Lee MS, Sim H, Ernst E. Acupuncture for treating temporomandibular joint disorders: a systematic review and meta-analysis of randomized, sham-controlled trials. J Dent 2011;39:341-350.    DOI
25 Gray RJ, Quayle AA, Hall CA, Schofield MA. Physiotherapy in the treatment of temporomandibular joint disorders: a comparative study of four treatment methods. Br Dent J 1994;176:257-261.    DOI
26 Herpich CM, Amaral AP, Leal-Junior EC, et al. Analysis of laser therapy and assessment methods in the rehabilitation of temporomandibular disorder: a systematic review of the literature. J Phys Ther Sci 2015;27:295-301.    DOI
27 Lotze M, Lucas C, Domin M, Kordass B. The cerebral representation of temporomandibular joint occlusion and its alternation by occlusal splints. Hum Brain Mapp 2012;33:2984-2993.    DOI
28 Lickteig R, Lotze M, Kordass B. Successful therapy for temporomandibular pain alters anterior insula and cerebellar representations of occlusion. Cephalalgia 2013;33:1248-1257.    DOI
29 Treede RD, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain 2015;156:1003-1007.    DOI
30 Roldan-Barraza C, Janko S, Villanueva J, Araya I, Lauer HC. A systematic review and meta-analysis of usual treatment versus psychosocial interventions in the treatment of myofascial temporomandibular disorder pain. J Oral Facial Pain Headache 2014;28:205-222.   DOI
31 International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia 2020;40:129-221.    DOI
32 Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain 2016;17(9 Suppl):T93-T107.    DOI
33 Maixner W, Diatchenko L, Dubner R, et al. Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain 2011;12(11 Suppl):T4-T11.e1-e2. 
34 Riley JL 3rd, Benson MB, Gremillion HA, et al. Sleep disturbance in orofacial pain patients: pain-related or emotional distress? Cranio 2001;19:106-113.    DOI
35 Sener S, Guler O. Self-reported data on sleep quality and psychologic characteristics in patients with myofascial pain and disc displacement versus asymptomatic controls. Int J Prosthodont 2012;25:348-352. 
36 Quartana PJ, Wickwire EM, Klick B, Grace E, Smith MT. Naturalistic changes in insomnia symptoms and pain in temporomandibular joint disorder: a cross-lagged panel analysis. Pain 2010;149:325-331.    DOI
37 de Iongh A. Patients need support to self manage their long term conditions. BMJ 2014;348:g2973. 
38 Mujakperuo HR, Watson M, Morrison R, Macfarlane TV. Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst Rev 2010;(10):CD004715. 
39 Mejersjo C, Wenneberg B. Diclofenac sodium and occlusal splint therapy in TMJ osteoarthritis: a randomized controlled trial. J Oral Rehabil 2008;35:729-738.    DOI
40 Ferrillo M, Giudice A, Marotta N, et al. Pain management and rehabilitation for central sensitization in temporomandibular disorders: a comprehensive review. Int J Mol Sci 2022;23:12164. 
41 Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: a review. J Can Dent Assoc 2017;83:h7. 
42 Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain 2002;16:64-70. 
43 Senye M, Mir CF, Morton S, Thie NM. Topical nonsteroidal anti-inflammatory medications for treatment of temporomandibular joint degenerative pain: a systematic review. J Orofac Pain 2012;26:26-32.